Telehealth for Breast Cancer

Recruiting at 6 trial locations

Overseen By Erin Bange, MD, MSCE

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Memorial Sloan Kettering Cancer Center

Disqualifiers: Therapeutic trial, Language not supported

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 6-12 months

1750 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how enhanced telehealth can simplify cancer care by reducing the need for in-person visits. Participants will either maintain their usual in-person care routine or try the new telehealth approach, which includes virtual check-ups and consultations. This trial targets patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least three prior medical oncology visits. The goal is to determine if patients can save time and money while still receiving quality care. As an unphased trial, it offers patients the opportunity to contribute to innovative care solutions that could simplify their treatment experience.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that enhanced telehealth is safe for breast cancer care?

Research shows that telehealth is a safe and effective way to support breast cancer care. Studies have found that patients consider telehealth convenient and helpful, increasing satisfaction with care without frequent trips to the doctor's office.

No major safety concerns have been reported with telehealth itself. Instead, it improves patients' quality of life by saving time and money on travel while still providing quality care.

While enhanced telehealth is still under study, current evidence suggests it is well-tolerated and safe for managing breast cancer care. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about Enhanced Telehealth (ET) for breast cancer because it offers a new way to deliver care that could make treatment more accessible and personalized. Unlike the usual practice pattern that relies heavily on in-person visits and traditional follow-ups, ET leverages digital tools to connect patients with their medical oncologists. This approach not only provides more frequent and flexible interactions but also may help in tailoring treatment plans more effectively to individual needs, potentially improving outcomes and patient satisfaction.

What evidence suggests that enhanced telehealth is effective for breast cancer care?

Research has shown that telehealth effectively helps manage breast cancer care. Studies have found that patients using telehealth find it more convenient and report greater satisfaction with their care. A review of multiple studies found that telehealth improves both physical and mental health for breast cancer patients. Specifically, telehealth can greatly enhance quality of life. This trial will compare the Enhanced Telehealth (ET) practice pattern with the Usual Practice Pattern (UPP) of the patient's medical oncologist. This suggests that telehealth might make managing breast cancer easier and more comfortable. ^{1 2 4 6 7}

Who Is on the Research Team?

Erin Bange, MD, MSCE

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for individuals with prostate or breast cancer. It's designed to help those who find it challenging to make frequent in-person visits to the hospital by offering an enhanced telehealth option.

Inclusion Criteria

I have breast or prostate cancer and have visited a medical oncologist at least 3 times at Memorial Sloan Kettering.

Exclusion Criteria

Patient is enrolled on a therapeutic clinical trial

Patients whose primary language is not currently supported by Epic.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive cancer care through enhanced telehealth or usual practice pattern

6-12 months

Telehealth and in-person visits as per assigned group

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 months

What Are the Treatments Tested in This Trial?

Interventions

• Enhanced Telehealth

Trial Overview The MATCH-UP trial is testing whether providing cancer care through enhanced telehealth methods can be as effective and safe as traditional in-person visits, potentially reducing the need for patients to travel.

How Is the Trial Designed?

Group I: Enhanced Telehealth (ET) Experimental Treatment 2 Interventions

Enhanced Telehealth (ET) practice pattern of patient's medical oncologist

Group II: Usual practice pattern (UPP) Active Control 2 Interventions

Usual practice pattern (UPP) of patient's medical oncologist

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials

1,998

Recruited

602,000+

Citations

1. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC12409339/

Telehealth Approach in Breast Cancer Care: A Systematic ... This systematic review aimed to identify the effectiveness of telehealth on clinical outcomes in breast cancer patients. Methods. This review ...

2. academic.oup.com academic.oup.com/oncolo/article/29/11/e1470/7715784

Patient-reported convenience and effectiveness of telehealth ... Overall, the study supports the integration of telehealth into breast cancer management practices to improve patient outcomes and satisfaction.

3. sciencedirect.com sciencedirect.com/science/article/pii/S2214782925000478

Evidence-based digital health interventions for breast ... We conducted an umbrella review to summarize the evidence on digital health interventions aimed at improving health-related outcomes for BCS.

4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC9602569/

Leveraging Telehealth for the Management of Breast Cancer Conclusion: Telemedicine offers promise to both providers and breast cancer survivors to improve the physical and mental health detriments of both cancer and ...

5. frontiersin.org frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1017343/full

Impact of telehealth interventions on physiological and ... Pooled results depict that telehealth interventions significantly improved the QOL score in breast cancer patients (SMD 0.48, 95% CI 0.03 to 0.92, p=0.04) ( ...

6. bmjopen.bmj.com bmjopen.bmj.com/content/15/6/e098198

Evaluation of a telehealth service to support breast cancer ... The aim of this research is to evaluate the effectiveness, adoption, acceptability, feasibility, fidelity and cost of this new Service.

7. healthcaredelivery.cancer.gov healthcaredelivery.cancer.gov/telehealth/trace-esi.html

TRACE Early-Stage Investigators I am the principal investigator of the MATCHES trial, studying an enhanced telehealth program for breast and prostate cancer patients, ...